Abstract

Two contract manufacturers of biologic drugs plan significant investments in the US. Fujifilm says it will spend more than $2 billion to establish a large-scale cell culture site in the US by 2025....

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call